Published in Am J Gastroenterol on October 01, 1992
Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis. Gut (2002) 1.45
Neutrophil mucosal involvement is accompanied by enhanced local production of interleukin-8 in ulcerative colitis. Gut (1993) 1.33
IL-5 and TNF-alpha participate in recruitment of eosinophils to intestinal mucosa in ulcerative colitis. Dig Dis Sci (2001) 1.12
Eosinophil activation in ulcerative colitis: studies on mucosal release and localization of eosinophil granule constituents. Dig Dis Sci (1998) 1.12
Measurement of in vivo rectal mucosal cytokine and eicosanoid production in ulcerative colitis using filter paper. Gut (2000) 1.06
Accumulation, activation, and survival of neutrophils in ulcerative colitis: regulation by locally produced factors in the colon and impact of steroid treatment. Int J Colorectal Dis (2008) 0.93
Evidence of local eosinophil activation and altered mucosal permeability in collagenous colitis. Dig Dis Sci (2001) 0.85
Biomarkers in the management of ulcerative colitis: a brief review. Ger Med Sci (2011) 0.84
Colonic secretory effect in response to enteral feeding in humans. Gut (1994) 0.79
Fecal Myeloperoxidase as a Biomarker for Inflammatory Bowel Disease. Cureus (2017) 0.75
Intact adrenocorticotropic hormone secretion but impaired cortisol response in patients with active rheumatoid arthritis. Effect of glucocorticoids. J Rheumatol (1996) 1.73
Circadian rhythm of serum interleukin-6 in rheumatoid arthritis. Ann Rheum Dis (1994) 1.73
Bronchial hyperresponsiveness to methacholine in patients with primary Sjögren's syndrome. Ann Rheum Dis (1991) 1.63
Characterization of fluids from the stomach and proximal jejunum in men and women. Pharm Res (1997) 1.60
Prognostic significance of the microvascular count in colorectal cancer. J Clin Oncol (1996) 1.59
Pericytes as collagen-producing cells in excessive dermal scarring. Lab Invest (1996) 1.58
Enhanced local production of complement components in the small intestines of patients with Crohn's disease. N Engl J Med (1990) 1.56
Regulation of granulocyte function by hyaluronic acid. In vitro and in vivo effects on phagocytosis, locomotion, and metabolism. J Clin Invest (1980) 1.56
Prefrontal sulcal prominence is inversely related to response to clozapine in schizophrenia. Biol Psychiatry (1991) 1.48
Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis. Gut (2002) 1.45
Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy. Ann Rheum Dis (1985) 1.41
Role of hyaluronan in acute pancreatitis. Surgery (2000) 1.39
Impaired glucose handling in active rheumatoid arthritis: relationship to peripheral insulin resistance. Metabolism (1988) 1.35
Cerebrospinal fluid ferritin in patients with cerebral infarction or bleeding. Acta Neurol Scand (1980) 1.34
Neutrophil mucosal involvement is accompanied by enhanced local production of interleukin-8 in ulcerative colitis. Gut (1993) 1.33
The timing of glucocorticoid administration in rheumatoid arthritis. Ann Rheum Dis (1997) 1.33
Hyaluronate in bronchoalveolar lavage fluid: a new marker in sarcoidosis reflecting pulmonary disease. Br Med J (Clin Res Ed) (1985) 1.31
Selective expression of interleukin 10, interferon gamma, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. Proc Natl Acad Sci U S A (1992) 1.31
Microvascular pericytes express platelet-derived growth factor-beta receptors in human healing wounds and colorectal adenocarcinoma. Am J Pathol (1993) 1.31
Enhancement of factor XII dependent reactions by eosinophil cationic protein. Thromb Res (1979) 1.30
Tissue localization of beta receptors for platelet-derived growth factor and platelet-derived growth factor B chain during wound repair in humans. J Clin Invest (1993) 1.29
Randomized comparison of straight and colonic J pouch anastomosis after low anterior resection. Ann Surg (1996) 1.26
Detection of circulating IgG aggregates and immune complexes using 125I protein A from Staphylococcus aureus. Ann Rheum Dis (1976) 1.25
Kinetic studies of phagocytosis. I. The serum independent particle uptake by PMN from patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum (1978) 1.24
Accumulation of hyaluronic acid in the alveolar interstitial tissue in bleomycin-induced alveolitis. Am Rev Respir Dis (1989) 1.24
Circulating hyaluronic acid levels vary with physical activity in healthy subjects and in rheumatoid arthritis patients. Relationship to synovitis mass and morning stiffness. Arthritis Rheum (1987) 1.23
Kinetic studies of phagocytosis of IgG-coated latex particles with a thrombocyte counter. J Lab Clin Med (1977) 1.22
Hyaluronan and type III procollagen peptide concentrations in bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis. Thorax (1989) 1.21
Raised serum hyaluronate levels in scleroderma: an effect of growth factor induced activation of connective tissue cells? Ann Rheum Dis (1985) 1.20
Pericardial tamponade caused by central venous catheters. World J Surg (1982) 1.19
Dynamic role of hyaluronan (HYA) in connective tissue activation and inflammation. J Intern Med (1997) 1.17
Sulphasalazine in ankylosing spondylitis. Ann Rheum Dis (1986) 1.16
Pulmonary involvement in ankylosing spondylitis. Ann Rheum Dis (1986) 1.16
Prognostic predictors in colorectal cancer. Dis Colon Rectum (1994) 1.13
Increase in activated T cells and reduction in suppressor inducer T cells in systemic sclerosis. Ann Rheum Dis (1990) 1.12
Eosinophil activation in ulcerative colitis: studies on mucosal release and localization of eosinophil granule constituents. Dig Dis Sci (1998) 1.12
Increased expression of platelet-derived growth factor type B receptors in the skin of patients with systemic sclerosis. Arthritis Rheum (1990) 1.11
Studies on the phagocytic activity of the granulocytes in psoriasis and palmoplantar pustulosis. Br J Dermatol (1983) 1.11
The jejunal secretion of histamine is increased in active Crohn's disease. Gastroenterology (1990) 1.11
Alveolar accumulation of fibronectin and hyaluronan precedes bleomycin-induced pulmonary fibrosis in the rat. Eur Respir J (1992) 1.10
Regional jejunal perfusion, a new in vivo approach to study oral drug absorption in man. Pharm Res (1992) 1.10
Impaired glucose handling in active rheumatoid arthritis: relationship to the secretion of insulin and counter-regulatory hormones. Metabolism (1987) 1.10
Cold-induced reversible myocardial ischaemia in systemic sclerosis. Lancet (1989) 1.10
Recruitment of type I collagen producing cells from the microvasculature in vitro. Exp Cell Res (1996) 1.10
Volvulus of the colon. A review of 93 cases and current aspects of treatment. Acta Chir Scand (1989) 1.08
Effects of serum and cations on the selective release of granular proteins from human netrophils during phagocytosis. Scand J Haematol (1979) 1.08
Hyaluronate and type III procollagen peptide concentrations in bronchoalveolar lavage fluid as markers of disease activity in farmer's lung. Br Med J (Clin Res Ed) (1987) 1.07
Effect of hyaluronic acid on phagocytosis of opsonized latex particles. Scand J Immunol (1980) 1.07
A new technique for segmental jejunal perfusion in man. Am J Gastroenterol (1989) 1.07
Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. I. Relativity to inflammatory activity. Arch Intern Med (1987) 1.07
Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. II. Effects of anti-inflammatory and disease-modifying drug treatment. Arch Intern Med (1987) 1.06
Hyaluronan (hyaluronic acid) in bronchoalveolar lavage fluid during the development of bleomycin-induced alveolitis in the rat. Am Rev Respir Dis (1989) 1.05
Serum osteocalcin in rheumatoid arthritis and other inflammatory arthritides: relation between inflammatory activity and the effect of glucocorticoids and remission inducing drugs. Ann Rheum Dis (1986) 1.05
Is 125I iothalamate an ideal marker for glomerular filtration? Kidney Int (1985) 1.05
Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion. Am J Gastroenterol (1999) 1.04
Development of a brief version of the Burn Specific Health Scale (BSHS-B). J Trauma (2001) 1.04
Response of anaemia in rheumatoid arthritis to treatment with subcutaneous recombinant human erythropoietin. Ann Rheum Dis (1992) 1.03
The effect of L-leucine on the absorption of levodopa, studied by regional jejunal perfusion in man. Br J Clin Pharmacol (1993) 1.03
Serum erythropoietin in rheumatoid arthritis and other inflammatory arthritides: relationship to anaemia and the effect of anti-inflammatory treatment. Br J Haematol (1987) 1.02
Monocyte activation in rheumatoid arthritis (RA): increased integrin, Fc gamma and complement receptor expression and the effect of glucocorticoids. Clin Exp Immunol (1999) 1.01
Eosinophil cationic protein in inflammatory synovial effusions as evidence of eosinophil involvement. Ann Rheum Dis (1984) 1.01
Paf-acether (platelet-activating factor) increases microvascular permeability and affects endothelium-granulocyte interaction in microvascular beds. Acta Physiol Scand (1983) 1.01
Hyaluronan content in the kidney in different states of body hydration. Kidney Int (2000) 1.01
Stromal expression of platelet-derived growth factor beta-receptor and platelet-derived growth factor B-chain in colorectal cancer. Lab Invest (1993) 1.00
The sex ratio and rate of reoperation for Dupuytren's contracture in men and women. J Hand Surg Br (1999) 1.00
Endotoxemia in chronic renal failure. Nephron (1987) 1.00
Hyaluronic acid accumulation and redistribution in rejecting rat kidney graft. Relationship to the transplantation edema. J Exp Med (1990) 0.99
Inhibitory effect of the flavonoid O-(beta-hydroxyethyl)-rutoside on increased microvascular permeability induced by various agents in rat skin. Int J Microcirc Clin Exp (1983) 0.99
Magnetic resonance imaging of sacroiliac joint inflammation. Arthritis Rheum (1990) 0.99
Sleep disturbances in patients with primary Sjögren's syndrome. Br J Rheumatol (1993) 0.98
Effect of fibrin degradation products on microvascular permeability. Thromb Res (1978) 0.98
Increased hyaluronan (hyaluronic acid) levels in bronchoalveolar lavage fluid after histamine inhalation. Int Arch Allergy Appl Immunol (1989) 0.98
Non-invasive assessment of left ventricular diastolic function in patients with systemic sclerosis. J Intern Med (1990) 0.97
Accumulation of hyaluronan and tissue edema in experimental myocardial infarction. J Clin Invest (1991) 0.97
Renal interstitial fibrosis and vascular changes. Occurrence in patients with autoimmune diseases treated with cyclosporine. Arch Intern Med (1986) 0.97
Immunohistological p53 staining is of limited value in the staging and prognostic prediction of colorectal cancer. Anticancer Res (1996) 0.97
Tumor cell and connective tissue cell interactions in human colorectal adenocarcinoma. Transfer of platelet-derived growth factor-AB/BB to stromal cells. Am J Pathol (1997) 0.96
Direct estimation of the in vivo dissolution of spironolactone, in two particle size ranges, using the single-pass perfusion technique (Loc-I-Gut) in humans. Eur J Pharm Sci (2001) 0.96
Anxiety and depression in patients with primary Sjögren's syndrome. J Rheumatol (2000) 0.96
Serum ferritin during infection. A longitudinal study. Scand J Haematol (1978) 0.95
Human serum inhibits the interaction between C1q or rheumatoid factor and IgG-coated latex particles. Reduction of these C1-dependent properties after complement activation in vitro and in vivo. Immunology (1979) 0.94
Vascular complications in the Ehlers-Danlos syndrome. Acta Chir Scand (1983) 0.94
Impaired glucose handling in active rheumatoid arthritis: effects of corticosteroids and antirheumatic treatment. Metabolism (1987) 0.93
Experimentally-induced warm renal ischemia induces cortical accumulation of hyaluronan in the kidney. Kidney Int (1996) 0.93
Low serum dehydroepiandrosterone sulfate in women with primary Sjögren's syndrome as an isolated sign of impaired HPA axis function. J Rheumatol (2001) 0.93
Sodium hyaluronate as an adjunct in adhesion prevention after flexor tendon surgery in rabbits. J Hand Surg Am (1992) 0.92
Stimulation of wound healing by epidermal growth factor. A dose-dependent effect. Ann Surg (1986) 0.92
Isolation of vasoactive peptides from human fibrin and fibrinogen degraded by plasmin. Thromb Res (1978) 0.91
The gut-joint axis: cross reactive food antibodies in rheumatoid arthritis. Gut (2006) 0.91
Lactoferrin, lysozyme, and beta 2-microglobulin levels in cerebrospinal fluid: differential indices of CNS inflammation. Inflammation (1982) 0.91
Signs of increased leakage over the jejunal mucosa during gliadin challenge of patients with coeliac disease. Gut (1990) 0.91